{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T10:31:16Z","timestamp":1648895476541},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,5,15]]},"DOI":"10.2169\/internalmedicine.3682-19","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T22:04:29Z","timestamp":1581458669000},"page":"1299-1302","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?"],"prefix":"10.2169","volume":"59","author":[{"given":"Hiroaki","family":"Aizawa","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Karasaki","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nagayama","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Shinozaki-Ushiku","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Tokyo Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Aburatani","sequence":"additional","affiliation":[{"name":"Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[{"name":"Division of Cellular Signaling, National Cancer Center Research Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Meter ME, Nye DJ, Galvez CR. Suspected pulmonary metastasis of actinic cutaneous squamous cell carcinoma. Case Rep Surg 2017: 4176071, 2017.","DOI":"10.1155\/2017\/4176071"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yatabe Y, Dacic S, Borczuk AC, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer. J Thorac Oncol 14: 377-407, 2019.","DOI":"10.1016\/j.jtho.2018.12.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pereira TC, Share SM, Magalh\u00e3es AV, et al. Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases. Appl Immunohistochem Mol Morphol 19: 10-14, 2011.","DOI":"10.1097\/PAI.0b013e3181ecaf1c"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kohsaka S, Tatsuno K, Ueno T, et al. Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Cancer Sci 110: 1464-1479, 2019.","DOI":"10.1111\/cas.13968"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest 151: 193-203, 2017.","DOI":"10.1016\/j.chest.2016.10.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wang CW, Wu TI, Yu CT, et al. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung. Am J Clin Pathol 131: 715-722, 2009.","DOI":"10.1309\/AJCPTPBC6V5KUITM"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ichinose J, Shinozaki-Ushiku A, Takai D, et al. Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 16: 403-410, 2016.","DOI":"10.1586\/14737140.2016.1147352"},{"key":"8","unstructured":"8. Yemelyanova A, Vang R, Kshirsagar M, et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 24: 1248-1253, 2011."},{"key":"9","unstructured":"9. Cheng DT, Mitchell TN, Zehir A, et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17: 251-264, 2015."},{"key":"10","unstructured":"10. Goto T, Hirotsu Y, Mochizuki H, et al. Mutational analysis of multiple lung cancers: discrimination between primary and metastatic lung cancers by genomic profile. Oncotarget 8: 31133-31143, 2017."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Carbone DP, Reck M, Paz-Ares L, et al. First-line nivolumab in stage IV or recurrent non-small-cell lung cancer. N Engl J Med 376: 2415-2426, 2017.","DOI":"10.1056\/NEJMoa1613493"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vignot S, Frampton GM, Soria JC, et al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol 31: 2167-2172, 2013.","DOI":"10.1200\/JCO.2012.47.7737"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366: 883-892, 2012.","DOI":"10.1056\/NEJMoa1113205"},{"key":"14","unstructured":"14. Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 72: 4875-4882, 2012."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/10\/59_3682-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T03:43:10Z","timestamp":1589600590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/10\/59_3682-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3682-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}